Minister’s comments reportedly contradict committee testimony.
Benefits paid were significantly higher than the previous two years.
Employer-sponsored drug insurance stakeholders invited to comment.
Lack of awareness continues to hinder use of group benefit programs.
The company improved its net income on the Canadian front.
Management underlines new business value growth.
Biosimilars Canada, a national association for the biosimilar medicines industry, is drawing attention to the recent imp